Objectives: The snorkel approach for EVAR has shown to be a safe and viable alternative to open repair for juxtarenal AAAs with good shortterm outcomes. Concerns about long-term durability and renal branch patency of this technique have been raised with increasing availability of fenestrated devices. We sought to evaluate renal function changes in patients undergoing Sn-EVAR.
Methods: Patients who underwent Sn-EVAR from 2009-2012 were included in this analysis. Creatinine values were obtained throughout the patient's pre-, peri-, and postoperative course. GFR was estimated using the simplified modification of diet in renal disease (MDRD) formula.
Chronic renal insufficiency was defined as pre-op serum creatinine >1.5 mg/dL. Postoperative renal dysfunction was stratified by two methods, creatinine increase >0.5 mg/dL as well as with the previously validated RIFLE classification system utilizing GFR.
Results: 43 consecutive patients underwent Sn-EVAR (32 double renal, 11 single renal) for jAAA. Mean follow-up time was 23 months. Mean aneurysm size was 6.6 cm (range, 5.3-10.5 cm) and unable to be treated with standard EVAR (mean neck length 1.7 mm). Six (13%) patients had baseline chronic renal insufficiency. 75 renal snorkel stents were successfully placed with a 2-year primary patency of 95%. Mean baseline, maximum postoperative, and latest follow up creatinine were 1.20, 1.62, and 1.45 respectively (P < .05). Mean baseline, maximum postoperative, and latest follow up GFR were 57.4, 46.3, and 49.5, respectively (P < .05). Seven patients (15.6%) developed chronic renal insufficiency based on creatinine levels alone. Thirteen patients (29%) had >25% decline in GFR (mild renal dysfunction), while two patients (4%) had a >50% decline (moderate renal dysfunction). No patients had >75% decline in GFR (severe renal dysfunction) or required long term dialysis. All-cause mortality at latest follow-up was 11%.
Conclusions: Midterm renal function changes for patients undergoing Sn-EVAR for jAAAs is favorable compared to published reports of open repair and f-EVAR. The majority of patients did not experience decline in renal function, and those that did have changes were classified as mostly mild. Sn-EVAR should continue to be considered an endovascular option for complex AAAs, especially in high-risk operative candidates. Objectives: Tortuous, highly calcified, severely stenotic or occluded iliac vessels may render endovascular repair of aortic aneurysms problematic or unsafe. Retroperitoneal conduit is a solution to this problem but has surgical risks and is not feasible in highly calcified vessels (Fig 2, A) . A promising alternative is the "Pave and Crack" technique. This typically consists of 10-12 mm intraluminal conduit (endoconduit) deployment in iliac vessels with coverage of the internal iliac artery (IIA). We present 3 cases from our institution and propose a method of appropriately selecting endoconduit diameter that addresses the increasing variety of aneurysm exclusion devices.
Dynamic
Methods and Results: Case 1: A 7.4-mm (minimum diameter) left CIA and 6.8-mm right CIA were predilated to 9 mm and lined with 10-Â 5-mm Viabahn and 8-Â 39-mm Atrium stent grafts, respectively. After 10-mm balloon dilation of these endoconduits, a 22F bifurcated device was deployed for successful aneurysm exclusion.
Case 2: A 6.5 mm diameter EIA was predilated to 8 mm and lined with a 10-Â 50-mm Viabahn stent graft that was postdilated to 9 mm. A 22F aortouniliac device was successfully passed and deployed, but the endoconduit was inadvertently pushed into the aneurysm sac and subsequently excluded as "endotrash."
Case 3: A severely stenotic CIA (5.8 mm) and EIA (4.2 mm) were initially predilated to 7 mm and 5 mm, respectively, and subsequently lined with 10-Â 5-mm and 10-Â 10-mm Viabahn stents, sparing the IIA. After postdilation to 10 mm, a 24F Medtronic bifurcated device passed through these endoconduits for successful aneurysm exclusion.
Conclusions: These cases reveal two key points: the relevance of endoconduit diameter selection and the safety of maintaining internal iliac 
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